Mark Clendenning Selected Research

Calcibiotic Root Canal Sealer

12/2023	Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X family.
3/2023	Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival.
2/2023	Evaluating Multiple Next-Generation Sequencing-Derived Tumor Features to Accurately Predict DNA Mismatch Repair Status.
1/2018	Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas.
9/2017	Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes.
2/2017	Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts.
10/2013	BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome.
1/2009	Analysis of families with Lynch syndrome complicated by advanced serrated neoplasia: the importance of pathology review and pedigree analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Clendenning Research Topics

Disease

34	Neoplasms (Cancer) 10/2023 - 05/2006
29	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 02/2008
15	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2020 - 08/2008
12	Microsatellite Instability 03/2023 - 02/2007
6	Colonic Neoplasms (Colon Cancer) 01/2021 - 05/2012
5	Endometrial Neoplasms (Endometrial Cancer) 02/2023 - 07/2013
5	Turcot syndrome 01/2019 - 01/2009
3	Breast Neoplasms (Breast Cancer) 01/2020 - 04/2010
3	Adenoma (Adenomas) 01/2018 - 07/2010
3	Polyps 06/2012 - 07/2010
1	Diabetes Mellitus 11/2019
1	Type 2 Diabetes Mellitus (MODY) 11/2019
1	Prostatic Neoplasms (Prostate Cancer) 12/2014
1	Necrosis 04/2010
1	Intellectual Disability (Idiocy) 02/2008
1	Agammaglobulinemia (Hypogammaglobulinemia) 02/2008
1	Astrocytoma (Pilocytic Astrocytoma) 02/2008

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2007
14	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 07/2013
8	Calcibiotic Root Canal SealerIBA 12/2023 - 01/2009
4	A-Form DNA (A-DNA)IBA 01/2016 - 08/2011
3	Epithelial Cell Adhesion MoleculeIBA 01/2021 - 11/2015
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 03/2015
3	Mismatch Repair Endonuclease PMS2IBA 09/2013 - 05/2006
2	Codon (Codons)IBA 01/2018 - 06/2013
2	Ethanol (Ethyl Alcohol)IBA 01/2017 - 01/2017
2	CalciumIBA 01/2016 - 03/2015
2	Hormones (Hormone)IBA 07/2015 - 04/2010
2	MucinsIBA 12/2013 - 07/2013
1	MutagensIBA 03/2023
1	colibactinIBA 03/2023
1	CholesterolIBA 11/2019
1	Triglycerides (Triacylglycerol)IBA 11/2019
1	Exonucleases (3' 5' Exonuclease)IBA 01/2018
1	NucleotidesIBA 11/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	O-(6)-methylguanineIBA 12/2016
1	MethyltransferasesIBA 12/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2016
1	Ibuprofen (Motrin)FDA LinkGeneric 09/2015
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2015
1	Contraceptive Agents (Contraceptives)IBA 07/2015
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2015
1	RNA Splice SitesIBA 06/2011
1	SmokeIBA 07/2010
1	SteroidsIBA 04/2010
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2010
1	Estrogen ReceptorsIBA 04/2010
1	EpitopesIBA 01/2009
1	Coloring Agents (Dyes)IBA 01/2009
1	Transcobalamins (Transcobalamin II)IBA 02/2008

Therapy/Procedure

3	Ligation 02/2017 - 08/2008
2	Precision Medicine 02/2023 - 01/2020
1	Drug Therapy (Chemotherapy) 01/2017
1	Hysterectomy 07/2015